Sell 9/29/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 9/29/2023 due to a noticeable increase in the volatility index.

Sell 9/12/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 9/12/2023 due to a noticeable decline in the volatility index.

Sell 8/23/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 8/23/2023 due to a noticeable increase in the volatility index.

Sell 8/7/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 8/7/2023 due to a noticeable decline in the volatility index.

Sell 7/17/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 7/17/2023 due to a noticeable increase in the volatility index.

Sell 6/30/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 6/30/2023 due to a noticeable decline in the volatility index.

Sell 6/12/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 6/12/2023 due to a noticeable increase in the volatility index.

Sell 5/26/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 5/26/2023 due to a noticeable decline in the volatility index.

Sell 5/11/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 5/11/2023 due to a noticeable increase in the volatility index.

Sell 4/26/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 4/26/2023 due to a noticeable decline in the volatility index.

Sell 4/10/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 4/10/2023 due to an increase in the volatility index.

Sell 3/23/2023Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 3/23/2023 due to a decline in the volatility index.

Sell 1/5/2023Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 1/5/2023 due to a large increase in the volatility index.

Sell 12/16/2022Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to D- from D on 12/16/2022 due to a large decline in the volatility index.

Sell 12/1/2022Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D from D- on 12/1/2022 due to a noticeable increase in the volatility index and total return index.

Sell 8/22/2022Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D- from E+ on 8/22/2022 due to a substantial increase in the solvency index, total return index and volatility index.

Sell 12/17/2020Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to E+ from D- on 12/17/2020 due to a decline in the volatility index.

Sell 12/1/2020Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D- from E+ on 12/1/2020 due to a noticeable increase in the total return index and volatility index.

Sell 6/5/2020Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to E+ from D- on 6/5/2020 due to a decline in the volatility index.

Sell 5/20/2020Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D- from E+ on 5/20/2020 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0031 to -$0.0007, EBIT increased 65.47% from -$209.4 to -$72.3, and operating cash flow increased 62.13% from -$218.1 to -$82.6.

Sell 11/6/2019Downgrade
CBD Life Sciences Inc. (CBDL) was downgraded to E+ from D- on 11/6/2019 due to a decline in the volatility index.

Sell 10/22/2019Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to D- from E+ on 10/22/2019 due to a substantial increase in the valuation index, growth index and solvency index.

Sell 8/13/2019Upgraded
CBD Life Sciences Inc. (CBDL) was upgraded to E+ from on 8/13/2019 due to a significant increase in the solvency index, valuation index and volatility index.